Medicare Enrolled
Dr. Girish Vallabhan, M.D.
Urology Physician · Lubbock, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vallabhan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vallabhan? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vallabhan
Dr. Girish Vallabhan is an urology physician in Lubbock, TX, with 20 years in practice. Based on federal Medicare data, Dr. Vallabhan performed 17,545 Medicare services across 7,744 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vallabhan received a total of $9,563 from 59 pharmaceutical and/or device companies across 309 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vallabhan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 4% volume in TX$ $9,563 industry payments
Medicare Practice Summary
Medicare Utilization ↗17,545
Medicare services
Top 4% in TX for urology physician
7,744
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~877 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 5,400 | $5 | $16 |
| Automated urinalysis | 2,328 | $2 | $9 |
| Office visit, established patient (20-29 min) | 1,464 | $59 | $177 |
| Blood draw (venipuncture) | 1,359 | $8 | $9 |
| PSA test (prostate cancer screening) | 1,213 | $18 | $70 |
| Bladder ultrasound after voiding | 869 | $7 | $54 |
| Ceftriaxone antibiotic injection | 763 | $0 | $20 |
| Office visit, established patient (30-39 min) | 640 | $94 | $262 |
| Infectious disease DNA/RNA test | 549 | $34 | $50 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 264 | $134 | $1,945 |
| Testosterone (hormone) level, total | 249 | $25 | $106 |
| Drug injection, under skin or into muscle | 215 | $11 | $72 |
| Ultrasound scan of pelvic region through rectum | 213 | $87 | $270 |
| Injection, garamycin, gentamicin, up to 80 mg | 211 | $2 | $20 |
| Complete blood count (CBC) with differential | 167 | $8 | $32 |
| Comprehensive metabolic blood panel | 165 | $10 | $43 |
| Diagnostic exam of bladder and urethra using an endoscope | 163 | $181 | $598 |
| Psa (prostate specific antigen) measurement, free | 128 | $18 | $70 |
| New patient office visit (45-59 min) | 125 | $123 | $404 |
| Limited ultrasound scan behind abdominal cavity | 116 | $43 | $168 |
| Electrocardiogram (EKG), 12-lead | 114 | $11 | $49 |
| Office visit, established patient, complex (40-54 min) | 69 | $133 | $354 |
| New patient office visit (30-44 min) | 61 | $70 | $265 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 59 | $25 | $92 |
| Hospital follow-up visit, moderate complexity | 59 | $60 | $179 |
| X-ray of abdomen, 1 view | 52 | $22 | $66 |
| Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 51 | $34 | $50 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 51 | $34 | $50 |
| Yeast/candida DNA test | 48 | $33 | $50 |
| Waterjet destruction of prostrate accessed through the urethra | 40 | $531 | $3,500 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 38 | $264 | $2,041 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 37 | $917 | $4,227 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 32 | $33 | $50 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 31 | $34 | $50 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 28 | $296 | $908 |
| Biopsy of prostate gland | 24 | $96 | $640 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 19 | $257 | $900 |
| Electronic assessment of bladder emptying | 19 | $5 | $45 |
| Injection of biodegradable material next to prostate | 19 | $2,251 | $10,018 |
| Limited ultrasound scan of pelvis | 19 | $32 | $138 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 17 | $25 | $554 |
| Insertion of device into abdomen with pressure and urine flow rate study | 15 | $143 | $375 |
| Initial hospital admission, moderate complexity | 15 | $95 | $341 |
| Surgical repair of vaginal defect using an endoscope | 14 | $729 | $2,920 |
| Simple bladder irrigation and/or instillation | 13 | $59 | $243 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,563
Total received (2018-2024)
Avg $1,366/year across 7 years
Top 21% in TX for urology physician
59
Companies
309
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,549 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$14 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,775
2023$1,674
2022$1,185
2021$1,135
2020$753
2019$2,097
2018$944
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,355
PROCEPT BioRobotics Corporation
$1,068
Dendreon Pharmaceuticals LLC
$855
Janssen Biotech, Inc.
$839
Astellas Pharma US Inc
$757
BOSTON SCIENTIFIC CORPORATION
$362
Intuitive Surgical, Inc.
$345
PFIZER INC.
$326
AbbVie Inc.
$239
ABBVIE INC.
$214
CooperSurgical, Inc.
$193
Myriad Genetic Laboratories, Inc.
$190
AstraZeneca Pharmaceuticals LP
$148
Sumitomo Pharma America, Inc.
$141
AMAG Pharmaceuticals, Inc.
$136
STORZ MEDICAL America, Inc.
$133
Endo Pharmaceuticals Inc.
$132
Bayer HealthCare Pharmaceuticals Inc.
$130
UROVANT SCIENCES INC
$127
AngioDynamics, Inc.
$127
Axonics, Inc.
$124
Photocure Inc
$118
Otsuka America Pharmaceutical, Inc.
$116
NeoTract Inc.
$111
Janssen Scientific Affairs, LLC
$91
Amgen Inc.
$77
SRS Medical Systems, Inc.
$72
Philips Electronics North America Corporation
$68
Allergan, Inc.
$66
UROGEN PHARMA, INC.
$61
Blue Earth Diagnostics Limited
$56
Baxter Healthcare
$54
Coloplast Corp
$53
UroGen Pharma, Inc.
$47
GENZYME CORPORATION
$43
Myovant Sciences Inc.
$41
Laborie Medical Technologies Corp.
$41
COLOPLAST CORP
$37
Innovation Technologies Inc
$37
Merck Sharp & Dohme Corporation
$33
Caldera Medical, Inc
$30
TOLMAR Pharmaceuticals, Inc.
$27
MENARINI SILICON BIOSYSTEMS, INC.
$26
Duchesnay USA Incorporated
$25
MEDIVATION FIELD SOLUTIONS LLC
$25
Medtronic, Inc.
$25
Alnylam Pharmaceuticals Inc.
$25
Cook Medical LLC
$25
Clovis Oncology, Inc.
$24
Antares Pharma, Inc.
$23
Merck Sharp & Dohme LLC
$21
Teleflex LLC
$20
Allergan Inc.
$20
Novartis Pharmaceuticals Corporation
$19
Ferring Pharmaceuticals Inc.
$15
BIOPROTECT MEDICAL, INC.
$14
Hollister Incorporated
$14
TherapeuticsMD, Inc.
$12
Acacia Pharma Inc
$12
Top 3 companies account for 34.3% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · AMS 700 · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Advincula Delineator Uterine Manipulator · Altis · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BRAC CDx · BYFAVO · Cellsearch · Cysview · Da Vinci Surgical System · Desara · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL BPH · GENERAL BPH · GENERAL THERAPIES · GENERAL FEMALE SUI · General - Female SUI · General - Therapies · IMVEXXY · INTERSTIM · INTRAROSA · IRRISEPT · JELMYTO · JEVTANA · JYNARQUE · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LithoVue · Luja Coude · MYRBETRIQ · MYRISK · Myrbetriq · NANOKNIFE · Nubeqa · ORGOVYX · OXLUMO · Oncology Solutions · Optilume BPH Drug Coated Balloon Catheter · Osphena · PERCLOT · PLUVICTO · PROLARIS · PROVENGE · Prolaris · Prolia · RESONANCE · REZUM · Rubraca · SPACEOAR VUE · SeeClear XcL Laparoscopic Smoke Evacuation System · SpeediCath · SuperCut Hysterectomy Scissors · TISSEEL · TOVIAZ · Titan · UROLIFT · UroCuff · UroLift · VaPro Plus Pocket · Vaginal Speculum - Snowman/ Pederson Blade · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $54 per 100 Medicare services performed
Geographic Context
Urology Physicians within 10 mi
16
Per 100K population
5.1
County median income
$63,367
Nearest hospital
EXCEPTIONAL COMMUNITY HOSPITAL LUBBOCK
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vallabhan is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vallabhan experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Vallabhan performed 5,400 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vallabhan receive payments from pharmaceutical companies?
Yes. Dr. Vallabhan received a total of $9,563 from 59 companies across 309 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vallabhan's costs compare to other urology physicians in Lubbock?
Dr. Vallabhan's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vallabhan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lubbock
Browse urology physicians in Lubbock ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology Physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
PROCEPT BioRobotics Corporation Payments to Doctors
See all physicians who received payments from PROCEPT BioRobotics Corporation.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology